本文選題：激活素A大腸癌 + 腫瘤標(biāo)記物��； 參考：《吉林大學(xué)》2016年博士論文

【摘要】：大腸癌是臨床上常見(jiàn)的惡性腫瘤之一,其發(fā)病率逐年上升。但目前對(duì)大腸癌的早期診斷及治療效果依然不甚理想。臨床上,急需更為有效的方法提高大腸癌的診斷效率及治療效果,使大腸癌患者從中獲益。激活素A具有多種生物學(xué)活性,包括參與多種腫瘤的發(fā)生、發(fā)展;盡管已有部分研究表明激活素A在大腸癌組織表達(dá),但關(guān)于大腸癌患者血清激活素A水平、激活素A對(duì)大腸癌細(xì)胞作用的信號(hào)轉(zhuǎn)導(dǎo)機(jī)制等仍未明確。因此,本研究檢測(cè)了健康對(duì)照者、大腸良性息肉及大腸癌患者血清激活素A水平,結(jié)果發(fā)現(xiàn)大腸癌患者血清激活素A水平較健康對(duì)照者及大腸良性息肉患者血清激活素A水平明顯升高,并且激活素A水平與大腸癌分期存在一定關(guān)聯(lián)。RT-PCR、Western blotting及免疫組織化學(xué)染色等結(jié)果確認(rèn)了激活素A是由大腸癌細(xì)胞分泌,提示激活素A可能成為輔助診斷大腸癌的新的腫瘤標(biāo)記物。本研究又通過(guò)吉姆薩染色及流式細(xì)胞術(shù)等方法檢測(cè)激活素A對(duì)大腸癌細(xì)胞系SW480細(xì)胞的作用,發(fā)現(xiàn)激活素A可以誘導(dǎo)SW480細(xì)胞凋亡。另外,本研究還通過(guò)基因敲低及過(guò)表達(dá)等方法證明激活素A通過(guò)Smads信號(hào)傳導(dǎo)途徑誘導(dǎo)SW480細(xì)胞凋亡。一、大腸癌患者血清及組織中激活素A水平變化1.健康對(duì)照者、大腸良性息肉患者及大腸癌患者血清激活素A水平應(yīng)用ELISA試劑盒檢測(cè)健康對(duì)照者、大腸良性息肉患者及大腸癌患者血清激活素A水平,結(jié)果發(fā)現(xiàn):大腸癌患者血清激活素A水平較健康對(duì)照者及大腸良性息肉患者血清激活素A水平明顯升高;大腸癌術(shù)后患者血清激活素A水平較術(shù)前明顯下降,提示大腸癌患者血清激活素A來(lái)源于大腸癌組織。2.激活素A在大腸癌組織中的表達(dá)應(yīng)用RT-PCR及Western blotting檢測(cè)激活素A m RNA及蛋白在大腸癌組織中的表達(dá)。結(jié)果顯示,大腸癌組織可高表達(dá)激活素A。免疫組織化學(xué)染色進(jìn)一步表明大腸癌細(xì)胞高表達(dá)激活素A。3.血清激活素A水平與大腸癌分期的關(guān)系大腸癌患者血清激活素A水平與其分期相關(guān),即I期大腸癌患者血清激活素A水平明顯低于II期、III期大腸癌患者,提示血清激活素A水平與大腸癌的術(shù)前分期有關(guān)。4.血清激活素A與癌胚抗原的比較與常用的大腸癌腫瘤標(biāo)記物癌胚抗原(CEA)相比,激活素A具有更高的特異性,故在臨床上,聯(lián)合應(yīng)用CEA及血清激活素A可能提高大腸癌診斷的準(zhǔn)確性。通過(guò)以上結(jié)果確認(rèn)了激活素A在大腸癌患者血清及組織中的表達(dá),并提示激活素A可能成為輔助診斷大腸癌的腫瘤標(biāo)記物。二、激活素A誘導(dǎo)大腸癌細(xì)胞系SW480發(fā)生凋亡的作用1.激活素A在大腸癌細(xì)胞系SW480中的表達(dá)應(yīng)用RT-PCR及Western blotting檢測(cè)大腸癌細(xì)胞系SW480細(xì)胞激活素A表達(dá),結(jié)果發(fā)現(xiàn)SW480細(xì)胞可表達(dá)激活素A。與前述實(shí)驗(yàn)結(jié)果相符。2.激活素A誘導(dǎo)SW480細(xì)胞凋亡實(shí)驗(yàn)采用MTT法測(cè)定細(xì)胞活力,結(jié)果提示:在外源性激活素A作用下,大腸癌細(xì)胞系SW480細(xì)胞活力減弱。應(yīng)用吉姆薩染色檢測(cè)激活素A對(duì)SW480細(xì)胞的作用。結(jié)果發(fā)現(xiàn):SW480細(xì)胞發(fā)生核固縮、凋亡小體等。提示激活素A可誘導(dǎo)SW480大腸癌細(xì)胞發(fā)生凋亡。進(jìn)一步應(yīng)用流式細(xì)胞術(shù)檢測(cè)激活素A對(duì)SW480的凋亡作用。結(jié)果顯示:激活素A可誘導(dǎo)SW480大腸癌細(xì)胞發(fā)生凋亡,且呈時(shí)間及濃度依賴(lài)性。3.激活素受體及Smad3在SW480細(xì)胞中的表達(dá)Smads途徑為經(jīng)典的激活素A信號(hào)轉(zhuǎn)導(dǎo)通路,本實(shí)應(yīng)用RT-PCR及Western blotting檢測(cè)了激活素A受體及Smad3在SW480細(xì)胞中的表達(dá)。結(jié)果發(fā)現(xiàn):激活素A處理的SW480細(xì)胞Smads通路的關(guān)鍵蛋白Smad3及Act RIIA與Act RIIB均升高,且呈濃度依賴(lài)性。提示激活素A可能通過(guò)Smads信號(hào)傳導(dǎo)途徑誘導(dǎo)SW480大腸癌細(xì)胞凋亡。三、Smad3基因敲低減弱激活素A誘導(dǎo)的SW480細(xì)胞凋亡作用SW480細(xì)胞轉(zhuǎn)染Smad3 sh RNA表達(dá)質(zhì)粒敲低Smad3基因表達(dá),再應(yīng)用流式細(xì)胞術(shù)檢測(cè)激活素A誘導(dǎo)SW480大腸癌細(xì)胞的凋亡作用。結(jié)果顯示,Smad3基因敲低后激活素A誘導(dǎo)SW480細(xì)胞凋亡明顯減少。該結(jié)果進(jìn)一步表明Smad3信號(hào)介導(dǎo)了激活素A誘導(dǎo)SW480大腸癌細(xì)胞凋亡作用。四、Smad3基因過(guò)表達(dá)對(duì)激活素A誘導(dǎo)SW480細(xì)胞凋亡作用的增強(qiáng)SW480細(xì)胞轉(zhuǎn)染Smad3表達(dá)質(zhì)粒,再應(yīng)用流式細(xì)胞術(shù)檢測(cè)激活素A誘導(dǎo)SW480大腸癌細(xì)胞的凋亡作用。結(jié)果顯示,Smad3基因過(guò)表達(dá)后激活素A誘導(dǎo)SW480細(xì)胞凋亡明顯增加。該結(jié)果進(jìn)一步確定Smad3信號(hào)介導(dǎo)了激活素A誘導(dǎo)SW480大腸癌細(xì)胞凋亡作用。結(jié)論:1.研究發(fā)現(xiàn)大腸癌患者血清激活素A水平升高,表明其可以作為大腸癌腫瘤標(biāo)記物用于臨床輔助診斷。2.研究表明激活素A用于大腸癌輔助診斷其特異性明顯高于CEA,更具有早期臨床樣本篩查價(jià)值。3.研究證實(shí)激活素A可誘導(dǎo)大腸癌SW480細(xì)胞凋亡,其作用與Smads信號(hào)傳導(dǎo)途徑有關(guān),提示激活素A也具有治療大腸癌的潛能。
[Abstract]:Colorectal cancer is one of the most common malignant tumors in the clinic, its incidence is increasing year by year. But the early diagnosis and treatment effect of colorectal cancer is still not ideal. In clinical, it is urgent to improve the diagnosis efficiency and treatment effect of colorectal cancer and make the patients with large intestine cancer benefit from it. The activin A has many biological activities. It is involved in the occurrence and development of a variety of tumors. Although some studies have shown that activin A is expressed in colorectal carcinoma, the level of serum activin A in colorectal cancer patients and the signal transduction mechanism of activin A on colorectal cancer cells are still not clear. Therefore, this study has been used to detect healthy controls, colorectal polyps and colorectal cancer patients. Serum activin A levels showed that serum activin A levels in patients with colorectal cancer were significantly higher than those of healthy controls and patients with benign colorectal polyps, and the levels of activin A were associated with.RT-PCR, Western blotting, and immunohistochemical staining, which confirmed that activin A is a large amount of A. The secretion of colon cancer cells suggests that activin A may be a new tumor marker to assist in the diagnosis of colorectal cancer. This study also detected the effect of activin A on SW480 cells in colorectal cancer cell lines by means of Giemsa staining and flow cytometry, and found that activin A can induce apoptosis of SW480 cells. The expression of activin A induced SW480 cell apoptosis through Smads signal transduction pathway. 1. Changes in serum and tissue activin A level in colorectal cancer patients 1. healthy controls, benign colorectal polyps and colorectal cancer patients serum activin A level using ELISA kit to detect healthy controls, patients with colorectal polyps and The serum activin A level in colorectal cancer patients showed that the serum activin A level of the patients with colorectal cancer was significantly higher than that of the healthy controls and the patients with benign colorectal polyps. The serum activin A level of the patients with colorectal cancer was significantly lower than that before the operation, suggesting that the serum activin A of the patients with colorectal cancer was derived from the.2. of the colorectal carcinoma tissue. The expression of activin A in colorectal carcinoma tissue using RT-PCR and Western blotting to detect the expression of activin A m RNA and protein in colorectal cancer tissue. The results show that the high expression of activin A. in colorectal cancer tissues is a further indication of the high expression activin A.3. serum activin A level in colorectal cancer cells and the score of colorectal cancer. Serum activin A level in patients with colorectal cancer is related to its stages, that is, serum activin A level in patients with stage I colorectal cancer is significantly lower than phase II, III stage colorectal cancer patients, suggesting that serum activin A level is related to the preoperative staging of colorectal cancer, which is related to the comparison of.4. serum activin A and carcinoembryonic antigen, and the common cancer markers for colorectal cancer. Compared with the antigen (CEA), activin A has a higher specificity. Therefore, the combination of CEA and serum activin A may improve the accuracy of the diagnosis of colorectal cancer. The expression of activin A in the serum and tissue of patients with colorectal cancer is confirmed by the above results, and the activin A may be a marker for the diagnosis of colorectal cancer. Two, activin A induced the apoptosis of colorectal cancer cell line SW480, 1. activin A expression in colorectal cancer cell line SW480, RT-PCR and Western blotting were used to detect the A expression of SW480 cell activin in colorectal cancer cell lines. The results showed that SW480 cells expressed activin A. consistent with the experimental results. MTT assay was used to determine cell viability. The results showed that the activity of SW480 cells in the colorectal cancer cell line was weakened under the effect of exogenous activin A. The effect of activin A on SW480 cells was detected by Giemsa staining. The results showed that SW480 cells had nuclear condensation and apoptotic bodies. It suggested that activin A can induce SW480 colorectal cancer cells to occur. Apoptosis. Further application of flow cytometry to detect the apoptotic effect of activin A on SW480. The results show that activin A can induce apoptosis in SW480 colorectal cancer cells, and the time and concentration dependent.3. activin receptor and the expression of Smad3 in SW480 cells are the classical activin A signal transduction pathway. This is a real application of RT-PCR and We. Stern blotting detected the expression of activin A receptor and Smad3 in SW480 cells. The results showed that the key protein Smad3 and Act RIIA and Act Act increased in the SW480 cell Smads pathway of activin A, and showed a concentration dependence. Smad3 sh RNA expression plasmid was transfected with Smad3 sh RNA expression plasmid to knock down the expression of Smad3 gene by knocking down the apoptosis induced by activin A, and then using flow cytometry to detect the apoptosis effect of activin A induced SW480 colorectal cancer cells. The results showed that the apoptosis of A inducement SW480 cells after the Smad3 gene knockdown was significantly reduced. The step indicated that the Smad3 signal mediated the apoptosis of SW480 colorectal cancer cells induced by activin A. Four, Smad3 gene overexpressed the apoptosis of SW480 cells induced by activin A, SW480 cells transfected with Smad3 expression plasmid, and then using flow cytometry to detect the apoptosis effect of activin A inducing SW480 colon cancer cells. The results showed that Smad3 gene was over. The expression of activin A induces a significant increase in apoptosis of SW480 cells. The results further confirm that the Smad3 signal mediates the apoptosis of SW480 colorectal cancer cells induced by activin A. Conclusion: 1. the increase of serum activin A level in colorectal cancer patients shows that it can be used as a tumor marker for colorectal cancer to be used in clinical auxiliary diagnosis of.2. research. Activin A is used in the diagnosis of colorectal cancer, its specificity is significantly higher than that of CEA, and it has a more early clinical sample screening value.3. study confirmed that activin A can induce apoptosis of SW480 cells in colorectal cancer, which is related to the Smads signal transduction pathway, suggesting that activin A also has the potential for the treatment of colorectal cancer.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2016
【分類(lèi)號(hào)】：R735.34

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊軍;張峰;;激活素A的基礎(chǔ)及臨床研究[J];黑龍江醫(yī)藥科學(xué);2009年06期

2 董輝,黃志紅,楊煜,柳忠輝;不同年齡段健康成年人外周血激活素A水平的變化[J];中國(guó)老年學(xué)雜志;2004年12期

3 安麗;王學(xué)燕;烏娟;;激活素對(duì)新生大鼠缺氧缺血性腦損傷后神經(jīng)元的保護(hù)[J];中國(guó)臨床康復(fù);2006年12期

4 于f ;王軼楠;楊清;孟小丹;孫洋;臺(tái)桂香;柳忠輝;;激活素A及激活素結(jié)合蛋白在急性酒精性肝損傷小鼠肝組織中的表達(dá)[J];中國(guó)生物制品學(xué)雜志;2011年03期

5 張宸豪;李瑤;方芳;李妍;;激活素的生理功能及其臨床意義的研究進(jìn)展[J];吉林醫(yī)藥學(xué)院學(xué)報(bào);2012年03期

6 王世瑤;柳忠輝;牟大鵬;張紅軍;楊瓊;常穎;臺(tái)桂香;;激活素受體相互作用蛋白4的基因克隆[J];吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2007年01期

7 裴穎;左玲;欒永昕;于維芹;蘇冠方;;激活素A對(duì)人皮膚微血管內(nèi)皮細(xì)胞周期的影響[J];中國(guó)老年學(xué)雜志;2009年05期

8 胡德恩;;調(diào)節(jié)細(xì)胞激活素在抗癌治療中的意義[J];國(guó)外醫(yī)學(xué)(腫瘤學(xué)分冊(cè));1992年05期

9 于曉明;友情是健康的激活素[J];中國(guó)保健營(yíng)養(yǎng);1997年10期

10 王曉琴;安麗;王平;鄭媛;趙東;;缺氧缺血性腦損傷與激活素A表達(dá)變化的相關(guān)性研究[J];山東大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2007年06期

相關(guān)會(huì)議論文 前10條

1 劉海巖;臺(tái)桂香;崔雪玲;陳芳芳;葛敬巖;柳忠輝;;激活素受體相互作用蛋白1，，2在小鼠組織中的表達(dá)及其功能研究[A];第六屆全國(guó)免疫學(xué)學(xué)術(shù)大會(huì)論文集[C];2008年

2 葛偉;;激活素在魚(yú)類(lèi)繁殖和發(fā)育中的調(diào)控作用[A];生命科學(xué)與生物技術(shù)：中國(guó)科協(xié)第三屆青年學(xué)術(shù)年會(huì)論文集[C];1998年

3 柳忠輝;張學(xué)軍;勞鳳學(xué);李一;;激活素受體相互作用蛋白3的基因克隆和鑒定[A];中國(guó)免疫學(xué)會(huì)第四屆學(xué)術(shù)大會(huì)會(huì)議議程及論文摘要集[C];2002年

4 張學(xué)軍;;巨噬細(xì)胞一氧化氮檢測(cè)及激活素對(duì)——氧化氮產(chǎn)生的調(diào)節(jié)機(jī)制[A];第五次全國(guó)中青年檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2006年

5 于玲;李俊;孔剛;李玉俠;尚濤;王雁玲;;激活素A對(duì)滋養(yǎng)層細(xì)胞浸潤(rùn)和凋亡的雙相作用[A];第一屆中華醫(yī)學(xué)會(huì)生殖醫(yī)學(xué)分會(huì)、中國(guó)動(dòng)物學(xué)會(huì)生殖生物學(xué)分會(huì)聯(lián)合年會(huì)論文匯編[C];2007年

6 袁發(fā)煥;李芙蓉;;激活素A及卵泡抑素對(duì)大鼠腎間質(zhì)成纖維細(xì)胞的影響[A];中華醫(yī)學(xué)會(huì)腎臟病學(xué)分會(huì)2006年學(xué)術(shù)年會(huì)論文集[C];2006年

7 宋綺穎;沈宗姬;;抑制素A和激活素A與胎兒生長(zhǎng)受限關(guān)系的研究[A];2011中國(guó)婦產(chǎn)科學(xué)術(shù)會(huì)議暨浙江省計(jì)劃生育與生殖醫(yī)學(xué)學(xué)術(shù)年會(huì)暨生殖健康講習(xí)班論文匯編[C];2011年

8 張學(xué)軍;姚智;;IL-1β在巨噬細(xì)胞中的檢測(cè)及激活素A對(duì)其活性的調(diào)節(jié)[A];第四屆全國(guó)臨床檢驗(yàn)學(xué)術(shù)會(huì)議論文匯編[C];2006年

9 柳忠輝;張鵬宇;張紅軍;張學(xué)軍;王世瑤;臺(tái)桂香;;ActRIPs介導(dǎo)的激活素調(diào)控小鼠巨噬細(xì)胞活性的信號(hào)傳導(dǎo)機(jī)制研究[A];中國(guó)免疫學(xué)會(huì)第五屆全國(guó)代表大會(huì)暨學(xué)術(shù)會(huì)議論文摘要[C];2006年

10 劉錫梅;尉紅;耿巖;;妊娠中期CRP、激活素A等水平與LBWF關(guān)系的研究[A];中華醫(yī)學(xué)會(huì)第二次全國(guó)產(chǎn)科熱點(diǎn)問(wèn)題研討會(huì)及第一屆全國(guó)產(chǎn)科主任論壇學(xué)術(shù)會(huì)議論文匯編[C];2004年

相關(guān)博士學(xué)位論文 前10條

1 吳雙;激活素A在人大腸癌組織中的表達(dá)及其作用研究[D];吉林大學(xué);2016年

2 李楠;激活素A調(diào)控單核巨噬細(xì)胞活性及其作用機(jī)制[D];吉林大學(xué);2013年

3 張紅軍;激活素受體相互作用蛋白2在小鼠肝細(xì)胞中的表達(dá)及其作用機(jī)制研究[D];吉林大學(xué);2007年

4 霍德勝;激活素A促炎作用研究[D];吉林大學(xué);2009年

5 徐桂月;激活素受體相互作用蛋白3的基因克隆及其特性研究[D];吉林大學(xué);2006年

6 張宸豪;激活素受體相互作用蛋白5基因克隆及其在小鼠胰腺組織中的表達(dá)和作用研究[D];吉林大學(xué);2010年

7 張學(xué)軍;激活素受體相互作用蛋白2在巨噬細(xì)胞中介導(dǎo)激活素信號(hào)傳導(dǎo)機(jī)制的研究[D];吉林大學(xué);2004年

8 李占東;人激活素受體結(jié)合蛋白2的克隆、鑒定及其與乳腺癌相關(guān)性的研究[D];東北師范大學(xué);2009年

9 李俊;激活素A對(duì)人早孕滋養(yǎng)層細(xì)胞凋亡的調(diào)節(jié)及與妊娠期高血壓疾病關(guān)系研究[D];中國(guó)醫(yī)科大學(xué);2005年

10 關(guān)愛(ài)華;激活素A與乳腺癌相關(guān)性的研究[D];吉林大學(xué);2007年

相關(guān)碩士學(xué)位論文 前10條

1 程序;激活素A的真核表達(dá)以及中藥抗腫瘤激活素A相關(guān)機(jī)制的初步探討[D];東北師范大學(xué);2008年

2 李繼茹;激活素A和脂多糖對(duì)小鼠腹腔巨噬細(xì)胞的活化作用及其機(jī)制研究[D];吉林大學(xué);2013年

3 李楠;激活素A誘導(dǎo)小鼠單核巨噬細(xì)胞分化和成熟的作用研究[D];吉林大學(xué);2010年

4 孔剛;不同濃度激活素A對(duì)細(xì)胞滋養(yǎng)層細(xì)胞行為的影響[D];中國(guó)醫(yī)科大學(xué);2006年

5 李海燕;激活素A對(duì)小鼠巨噬細(xì)胞白細(xì)胞介素6表達(dá)調(diào)控的研究[D];吉林大學(xué);2006年

6 徐妍婷;胎盤(pán)中激活素受體的表達(dá)及與胎兒生長(zhǎng)受限的關(guān)系[D];蘇州大學(xué);2014年

7 謝姣;激活素A及其信號(hào)蛋白在小鼠肝切除再生中的表達(dá)研究[D];吉林大學(xué);2008年

8 常霞;激活素A對(duì)新生大鼠缺氧缺血性腦損傷后腦組織巢蛋白的影響[D];山西醫(yī)科大學(xué);2010年

9 宋春雷;草魚(yú)激活素Ⅰ型和Ⅱ型受體的cDNA克隆、結(jié)構(gòu)分析及其在垂體細(xì)胞中的表達(dá)調(diào)控的研究[D];電子科技大學(xué);2009年

10 常穎;激活素A促進(jìn)人晶狀體上皮細(xì)胞增殖作用的研究[D];吉林大學(xué);2006年

本文編號(hào)：2053040